Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib with Gemcitabine and Carboplatin in Advanced NSCLC
NCT00326599Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Started Jun 2007; status: completed.
02
Drugs
cediranib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00326599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326599.